conference_3

Biointron will be participating in the Festival of Biologics 2024 - Europe, scheduled for October 15-17, 2024, at the Congress Center Basel in Switzerland. This prestigious event is a key gathering for professionals in the biologics industry, and we are eager to showcase our latest advancements and connect with industry leaders.

The Next-Gen Immuno-Oncology Conference 2024 in Boston featured advances in immunotherapy. Biointron shares insights driving future antibody-based treatments.

Taking place from September 30 to October 3, 2024, Discovery on Target 2024 is renowned for its comprehensive program, featuring keynote presentations, breakout sessions, and interactive panel discussions. The conference covers a wide range of topics, including target identification and validation, hit-to-lead optimization, and novel therapeutic modalities. It offers attendees the opportunity to stay at the forefront of the drug discovery field and to engage in meaningful discussions with peers and experts.

We are excited to announce that Biointron will be attending BIO Japan 2024, set to take place from October 9 to 11, 2024, in Yokohama, Japan. As Asia's largest event for the biotechnology industry, BIO Japan brings together industry leaders, researchers, and professionals to explore the latest advancements and innovations in biotechnology.

We are delighted to announce that Biointron will be participating in the Biologics USA 2024 conference, taking place from October 3 to 4, 2024, in San Diego, California. This event is a premier gathering for the biologics sector, providing a unique platform for industry leaders, researchers, and professionals to discuss the latest advancements and trends in biologics.

We are delighted to announce that Biointron will be participating in the 15th Annual World Bispecific Summit, scheduled to take place from September 3 to 5, 2024, in Boston, Massachusetts. This summit is a cornerstone event for the bispecific antibody community, attracting thought leaders and industry experts worldwide to discuss the latest innovations and breakthroughs in bispecific therapeutics.

We are excited to announce that Biointron will be participating in the upcoming BIO Asia - Taiwan Conference, set to take place from July 24 to 28, 2024, at the Taipei Nangang Exhibition Center. This prestigious event is a major gathering for the biotechnology and pharmaceutical industries, attracting professionals and companies from around the globe.

We are pleased to announce that Biointron will be attending the Next-gen Immuno-Oncology Conference 2024, scheduled for June 20-21, 2024, in Boston, Massachusetts. This distinguished event, organized by MarketsandMarkets, brings together leading experts, researchers, and industry professionals to discuss the latest advancements and trends in immuno-oncology.

AET Europe 2024 in London spotlighted antibody innovation. Biointron shares event takeaways on discovery, engineering, and development shaping the therapeutic pipeline.

BIO 2024 in San Diego showcased biotech innovation. Biointron reports highlights on antibody discovery, engineering, and collaborations shaping the future of biologics.

Are you an antibody professional? Are you planning which conference to attend for the rest of 2024 and couldn’t decide? Don’t worry; Biointron has you covered with our selected list of top antibody-related conferences!

PEGS Boston 2024 spotlighted protein and antibody engineering advances. Biointron reports event highlights that define the next era of therapeutic innovation.

We are delighted to announce that Biointron will be attending the Antibody Therapeutics Xchange 2024 Boston, which will take place on June 17, 2024. This exclusive event is a gathering of the leading minds in antibody therapeutics, offering a unique platform for collaboration, innovation, and knowledge sharing.

We are excited to announce that Biointron will be attending the Chinese Biopharmaceutical Association (CBA) 29th Annual Conference on June 9, 2024. This prestigious event will be held at the Marriott Washingtonian Center (Gaithersburg, Maryland), bringing together leading professionals, researchers, and companies in the biopharmaceutical industry.

CAS 2024 showcased breakthroughs in cancer research and antibody therapeutics. Biointron shares highlights shaping future directions in discovery and development.